Acumen Pharmaceuticals In... (ABOS)
1.23
-0.05 (-3.91%)
At close: Mar 03, 2025, 11:32 AM
Company Description
Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease.
The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers.
Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.
Acumen Pharmaceuticals Inc.
| Country | United States |
| IPO Date | Jul 1, 2021 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 51 |
| CEO | Daniel J. O'Connell M.B.A. |
Contact Details
Address: 427 Park Street Charlottesville, Virginia United States | |
| Website | https://acumenpharm.com |
Stock Details
| Ticker Symbol | ABOS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001576885 |
| CUSIP Number | 00509G209 |
| ISIN Number | US00509G2093 |
| Employer ID | 36-4108129 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Daniel J. O'Connell M.B.A. | Chief Executive Officer & Director |
| Derek M. Meisner Esq., J.D. | Chief Legal Officer & Corporate Secretary |
| Matt Zuga | Chief Financial Officer & Chief Business Officer |
| Russell Barton M.S. | Chief Operating Officer |
| Alex Braun M.B.A. | Vice President & Head of Investor Relations |
| Dr. Caleb E. Finch Ph.D. | Co-Founder |
| Dr. Grant A. Krafft Ph.D. | Co-Founder |
| Dr. James Doherty Ph.D. | President & Chief Development Officer |
| Dr. William L. Klein Ph.D. | Co-Founder |
| Kelly Carranza | Vice President, Finance & Accounting and Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 23, 2025 | 4 | Filing |
| Jan 23, 2025 | 4 | Filing |
| Jan 23, 2025 | 4 | Filing |
| Jan 23, 2025 | 4 | Filing |
| Jan 23, 2025 | 4 | Filing |
| Jan 07, 2025 | 4 | Filing |
| Jan 07, 2025 | 4 | Filing |
| Jan 07, 2025 | 4 | Filing |
| Jan 07, 2025 | 4 | Filing |
| Jan 07, 2025 | 4 | Filing |